Azathioprine or methotrexate added to adalimumab for Crohn’s
Treatments studied
Part of Digestive system clinical trials.
This trial compares two medicine options (azathioprine vs methotrexate) when added to adalimumab to treat active Crohn’s disease. It may help determine which add-on works better for people whose Crohn’s is still active despite standard treatments or who can’t take them.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are over 18 years old and have Crohn’s disease for at least 6 weeks.
- Your Crohn’s symptoms are currently “active” and your study score is above 150 (CDAI).
- You have signs of active inflammation seen during a scope/colonoscopy (endoscopy score above 4).
- You are not responding to usual treatments, or you can’t tolerate them, or they are not safe for you—especially for starting adalimumab.
- You have not previously taken adalimumab, and you have not been unable to tolerate azathioprine or methotrexate in the past.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial compares a steroid called prednisolone to a special diet (aCDED with PEN) for treating Crohn's disease flare-ups. It aims to see which approach helps improve quality of life.
This trial tests a special diet (CDED) combined with anti-TNF medication (infliximab or adalimumab) to see if it's safe and works better for active Crohn's disease. It may help if you haven't used these drugs before and can follow the diet.
This study tests whether starting adalimumab along with partial enteral (tube or drink) nutrition helps control active Crohn’s disease. It may help reduce symptoms and inflammation compared with standard care alone.
This Phase 2 trial tests whether taking azithromycin (an antibiotic) before starting infliximab or adalimumab can reduce the chance your body rejects the anti‑TNF medicine. It may help some people get better and keep responding to treatment.
This study tests a combination of two drugs, infliximab and azathioprine, to see if it works better than either drug alone for children with moderate to severe Crohn's disease. The trial is for children who have not used these drugs before.
This study compares two combination treatments for rheumatoid arthritis in people whose current methotrexate or leflunomide isn’t working well enough. It aims to see whether adding a targeted therapy works better than the standard add-on of sulfasalazine plus hydroxychloroquine.
Hear when a new Methotrexate trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.